In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Corgenix Medical Corporation

http://www.corgenix.com

Latest From Corgenix Medical Corporation

China Dips Its Toes in Disruptive IVD Tech

The number of Chinese IVD companies exhibiting at the 2015 American Association for Clinical Chemistry Annual Meeting (AACC) & Clinical Lab Expo (CLE) was slightly down from last year, but the breadth of diagnostic products and innovations from China appears to be on the up. Hrishi Poola and Jon Chen discuss the moves China is making to become a generator of disruptive technologies and reports on the new products and the players emerging from this market

Medical Device China

Presbyopia: A Broadening Market Accommodates New Medtech Innovations

The arrival of a new generation of intraocular lenses and corneal inlays – designed to offer clearer, improved vision without the need for reading glasses – is expected to spur growth in the presbyopia market.

Medical Device

CrownBio Aims For Gold Amid China Precision Medicines Rush

Another week has seen another plethora of deals between Chinese domestic players and global gene sequencing firms. Rising demand for individualized treatments and the rush for cancer immuno-therapies is propelling fast growth for the US-Chinese biotech company Crownbio, says its executive chairman Guo-Liang Yu.

China Personalized Medicine

Rapid Ebola Immunoassay From Corgenix Gains Authorization

The firm's ReEBOV assay, which can deliver results within 15-25 minutes, is the first rapid test and immunoassay for the Ebola virus granted an emergency use authorization by FDA.

Medical Device Regulation
See All

Company Information

UsernamePublicRestriction

Register